Vistin Pharma ASA: Invitation to Q1 2024 conference call
Oslo, Norway, 16 April 2024 Vistin Pharma ASA will release its first quarter results on Wednesday 24th of April 2024....
Year: 2024
Voyager Therapeutics Announces Selection of Development Candidate for GBA1 Program in Collaboration with Neurocrine Biosciences, Triggering Milestone Payment
LEXINGTON, Mass., April 16, 2024 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic...
Treace Announces First Annual National Bunion Day
Focus on Foot Health Issue Affecting Millions of People Includes Outreach and Education Efforts to Build Awareness, Reduce Stigma and...
Marizyme Enters Into Co-Development Agreement With Qualigen Therapeutics for the Commercialization of FDA-Cleared DuraGraft™
JUPITER, FL, April 16, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- Marizyme, Inc. ("Marizyme", OTCQB: MRZM) announces today a Co-Development Agreement (the...
QuantHealth Appoints Esteemed Pharmaceutical Executives to Inaugural Advisory Board
Leveraging Decades of Experience at AbbVie, Novartis and Biogen, This Advisory Board Will Advocate for AI Integration Within Clinical Trials ...
FendX Technologies to Participate at Upcoming Capital Events Management Investor Conference and Provides Corporate Update
Oakville, Ontario--(Newsfile Corp. - April 16, 2024) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the "Company" or...
Spago Nanomedical Strengthens Management with Head of CMC & Supply
LUND, SWEDEN / ACCESSWIRE / April 16, 2024 / Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F) Spago Nanomedical AB (publ) today announced the appointment...
Juva Life Unveils New Cannabis Vape Category – Rosin Absolute – Introduces Infused Flower Offerings and Announces Partnership With Cloudius9
REDWOOD CITY, CA / ACCESSWIRE / April 16, 2024 / Juva Life Inc. (CSE:JUVA)(OTCQB:JUVAF)(FRANKFURT:4VV) ("Juva Life" or the "Company"), Juva...
IRLAB to Present at Redeye Investor Forum
GOTHENBURG, SWEDEN / ACCESSWIRE / April 16, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, April 16, 2024 - IRLAB Therapeutics...
Multicancer Screening Market Projected to Reach $2.72 billion by 2030 – Exclusive Report by 360iResearch
PUNE, India, April 15, 2024 /PRNewswire/ -- The report titled "Multicancer Screening Market by Product (AI and Machine Learning-Based Platforms,...
LevelJump Announces That It Will Be Delayed in Filing Year-End Reporting Documents
Toronto, Ontario--(Newsfile Corp. - April 15, 2024) - LevelJump Healthcare Corp. (TSXV: JUMP) ("LevelJump" or the "Company") announces today that...
New Legislation Promotes Diversity in Allied Health Professions, Including AARC Respiratory Therapists
IRVING, TX / ACCESSWIRE / April 15, 2024 / A bill introduced on Monday, April 15, will pave the way...
Novo Integrated Sciences Reports Fiscal Year 2024 Second Quarter Financial Results
BELLEVUE, Wash.--(BUSINESS WIRE)--$NVOS #AAPI--Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the “Company” or “Novo”), pioneering a holistic approach to patient-first health and...
NuGen Announces Debt Settlement and Amendments to Care4Pharma Share Purchase Agreement
Toronto, Ontario--(Newsfile Corp. - April 15, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") announces that...
Convatec launches new Esteem Body™ with Leak Defense™
Latest ostomy system advancement in soft convexity BRIDGEWATER, N.J., April 15, 2024 /PRNewswire/ -- Convatec, a leading global medical products...
Charlie’s Holdings Reports 2023 Results Highlighted by the Launch of SPREE BAR(TM) with Proprietary Metatine(TM) Inside
COSTA MESA, CA / ACCESSWIRE / April 15, 2024 / Charlie's Holdings, Inc. (OTCQB:CHUC) ("Charlie's" or the "Company"), an industry...
Adastra Holdings Announces Lachlan McLeod as Interim CEO
LANGLEY, BC / ACCESSWIRE / April 15, 2024/ Adastra Holdings Ltd. (CSE:XTRX)(FRA:D2EP) ("Adastra" or the "Company"), a leading cannabis processor...
Aptevo Therapeutics Announces Closing of $4.6 Million Public Offering
SEATTLE, WA / ACCESSWIRE / April 15, 2024 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing...
Fresenius Accelerates Momentum in its (Bio)Pharma Business and Launches Tyenne®, its Third Approved Biosimilar in the U.S.
Tyenne® is the first tocilizumab biosimilar by Fresenius Kabi, an operating company of Fresenius SE, with an intravenous and subcutaneous...
Launch of a New Exciting Mental Health App, BetterEDU, for Group Peer Support
BetterEDU Launches Groundbreaking Peer-to-Peer Support App, Prioritizing College Students' Mental WellnessThe new free app BetterEDU works toward connecting students for...